Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Blackstone, a private investment firm, has closed on its first fund in the life sciences, Blackstone Life Sciences, with $4.6 billion in total capital commitments. The fund is focused on three main investment strategies: strategic collaborations...

More than 20 biopharmaceutical companies have announced their participation in the AMR Action Fund to support research of new antibiotics to address the rise of antibiotic-resistant infections, also called antimicrobial resistance (AMR), with a...

Amgen has made an additional investment of $421 million in BeiGene, a Beijing-based pharmaceutical company, which builds on a $2.8-billion drug-development and commercialization pact that the companies finalized earlier this year (2020). In...

A roundup of news from China (Boehringer Ingelheim), Europe (J&J), and the US (Lupin, Merck & Co., Sandoz, Civica Rx, and Mylan). China Boehringer Ingelheim Launches External Innovation Hub in ChinaBoehringer Ingelheim (BI) is launching...